Inveready signs an investment agreement with biotech company Lev2050
Stellum Food&Tech and Inveready Asset Management through its Inveready Biotech IV vehicle have joined the shareholding of the Navarre-based biotechnology company LEV 2050 to drive its growth.
March 26, 2024
Stellum Food&Tech, an investment vehicle of private equity firm Stellum Capital, and Inveready Asset Management through its Inveready Biotech IV vehicle (both vehicles supported by SODENA), have joined the shareholding of the Navarre-based biotechnology company LEV 2050 to drive its growth. Specifically, they have acquired a 25% stake in the company specializing in the development of microorganisms and yeast, as well as the design and manufacture of patented bioreactors to enhance production processes for companies in the agri-food sector.
26/03/2024
Inveready signs an investment agreement with biotech company Lev2050
Stellum Food&Tech and Inveready Asset Management through its Inveready Biotech IV vehicle have joined the shareholding of the Navarre-based biotechnology company LEV 2050 to drive its growth.